Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bora Pharmaceuticals Co's dividends per share for the
three
months ended in Dec. 2025 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$11.67. Its Dividend Payout Ratio for the
three
months ended in Dec. 2025 was 0.00. As of today, Bora Pharmaceuticals Co's Dividend Yield % is 2.95%.
During the past 12 months, Bora Pharmaceuticals Co's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 78.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 83.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 63.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bora Pharmaceuticals Co was 104.70% per year. The lowest was 2.00% per year. And the median was 84.45% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Bora Pharmaceuticals Co (TPE:6472) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Bora Pharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Bora Pharmaceuticals Co was 1.40. The lowest was 0.08. And the median was 0.36.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of Bora Pharmaceuticals Co was 3.37%. The lowest was 0.23%. And the median was 1.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bora Pharmaceuticals Co Dividends per Share Related Terms
Bora Pharmaceuticals Co Dividends per Share Historical Data
* Premium members only.
The historical data trend for Bora Pharmaceuticals Co's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6472 vs ZTS, UTHR: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bora Pharmaceuticals Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Bora Pharmaceuticals Co's Dividend Yield % falls into.
Bora Pharmaceuticals Co (TPE:6472) has a Dividends per Share of NT$11.67 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Bora Pharmaceuticals Co and its competitors.
Is Bora Pharmaceuticals Co's Dividends per Share too high?
Bora Pharmaceuticals Co's current Dividends per Share is NT$11.67. Overall, Bora Pharmaceuticals Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bora Pharmaceuticals Co's Dividends per Share compare to ZTS and UTHR?
Bora Pharmaceuticals Co's Dividends per Share of NT$11.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Bora Pharmaceuticals Co and its competitors. Bora Pharmaceuticals Co's current Dividends per Share is NT$11.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bora Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co (TPE:6472) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$736.58, compared to a current price of NT$392.50 — trading 46.7% below its estimated fair value. The current Dividends per Share is NT$11.67. Bora Pharmaceuticals Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Bora Pharmaceuticals Co (TPE:6472), the current Dividends per Share is NT$11.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bora Pharmaceuticals Co (TPE:6472) Overvalued in 2026?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$392.50 is trading 46.7% below its estimated GF Value™ of NT$736.58.
GuruFocus considers Bora Pharmaceuticals Co to be Significantly Undervalued.
Key valuation signals for TPE:6472:
Dividends per Share: NT$11.67
GF Value™: NT$736.58 vs. price of NT$392.50 (46.7% below fair value)
No single metric tells the full story. See the TPE:6472 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Sales segment: sale of pharmaceuticals, generics, and healthcare products. CDMO segment: contract development and manufacturing organization of pharmaceuticals. Other segment: Others. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
83GF Score
Get the complete analysis for TPE:6472
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6472 has been successfully added to your 
